Skip to content

Lunai Bioworks Inc.

LNAI · XNAS

CIK 1527728fmd_0EFRC98FW9RP792ZRH1Q2JHTFTManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2010 to Jun 30, 2026, 62 periods

Latest annual · FY2026

Millions
Total revenues
0
Operating income
(9)
Net income
(4)
Free cash flow
(5)

Latest quarter · Q4 FY2026

Millions
Total revenues
0
Gross profit
0
Operating income
(2)
Net income
(2)
Free cash flow
(2)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2023 to FY2026
n/m
Revenue, 5 yearsFY2021 to FY2026
n/m
Net income, 5 yearsFY2021 to FY2026
n/m

Lunai Bioworks Inc. (LNAI) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2026FY2025ChangeSource
Revenue$51,99210-K 2026-10-13 · proof
Operating income-$8.7 million-$189 million10-K 2026-10-13 · proof
Net income-$3.6 million-$178 million10-K 2026-10-13 · proof
Cash from operating activities-$5.3 million-$7.9 million10-K 2026-10-13 · proof
Free cash flow-$5.3 million10-K 2026-10-13 · proof
Total assets$9.9 million$8.2 million+20.8%10-K 2026-10-13 · proof
Total liabilities$19 million$29.6 million-35.9%10-K 2026-10-13 · proof
Cash and cash equivalents$1.7 million$92,700+1,748.6%10-K 2026-10-13 · proof
What was Lunai Bioworks Inc. (LNAI)'s revenue in fiscal 2026?
Lunai Bioworks Inc. (LNAI) reported revenue of $51,992 for fiscal 2026 (the year ended Jun 30, 2026). Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What was Lunai Bioworks Inc. (LNAI)'s operating income in fiscal 2026?
Lunai Bioworks Inc. (LNAI) reported operating income of -$8.7 million for fiscal 2026 (the year ended Jun 30, 2026), against -$189 million the year before. Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What was Lunai Bioworks Inc. (LNAI)'s net income in fiscal 2026?
Lunai Bioworks Inc. (LNAI) reported net income of -$3.6 million for fiscal 2026 (the year ended Jun 30, 2026), against -$178 million the year before. Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What was Lunai Bioworks Inc. (LNAI)'s cash from operating activities in fiscal 2026?
Lunai Bioworks Inc. (LNAI) reported cash from operating activities of -$5.3 million for fiscal 2026 (the year ended Jun 30, 2026), against -$7.9 million the year before. Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What was Lunai Bioworks Inc. (LNAI)'s free cash flow in fiscal 2026?
Lunai Bioworks Inc. (LNAI) reported free cash flow of -$5.3 million for fiscal 2026 (the year ended Jun 30, 2026). Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What are Lunai Bioworks Inc. (LNAI)'s total assets?
As of Jun 30, 2026, Lunai Bioworks Inc. (LNAI) reported total assets of $9.9 million, against $8.2 million a year earlier (+20.8%). Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What are Lunai Bioworks Inc. (LNAI)'s total liabilities?
As of Jun 30, 2026, Lunai Bioworks Inc. (LNAI) reported total liabilities of $19 million, against $29.6 million a year earlier (-35.9%). Source: the 10-K filed with the SEC on Oct 13, 2026. SEC
What are Lunai Bioworks Inc. (LNAI)'s cash and cash equivalents?
As of Jun 30, 2026, Lunai Bioworks Inc. (LNAI) reported cash and cash equivalents of $1.7 million, against $92,700 a year earlier (+1,748.6%). Source: the 10-K filed with the SEC on Oct 13, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:LNAI&period_type=annual&limit=5"

Information only, not investment advice.